全文获取类型
收费全文 | 82001篇 |
免费 | 8248篇 |
国内免费 | 5326篇 |
专业分类
耳鼻咽喉 | 778篇 |
儿科学 | 1459篇 |
妇产科学 | 821篇 |
基础医学 | 7696篇 |
口腔科学 | 1581篇 |
临床医学 | 10727篇 |
内科学 | 9952篇 |
皮肤病学 | 924篇 |
神经病学 | 3014篇 |
特种医学 | 2955篇 |
外国民族医学 | 24篇 |
外科学 | 7672篇 |
综合类 | 17193篇 |
现状与发展 | 23篇 |
一般理论 | 4篇 |
预防医学 | 7136篇 |
眼科学 | 1905篇 |
药学 | 9144篇 |
96篇 | |
中国医学 | 6563篇 |
肿瘤学 | 5908篇 |
出版年
2024年 | 361篇 |
2023年 | 1375篇 |
2022年 | 3507篇 |
2021年 | 4352篇 |
2020年 | 3538篇 |
2019年 | 2533篇 |
2018年 | 2541篇 |
2017年 | 2778篇 |
2016年 | 2385篇 |
2015年 | 3818篇 |
2014年 | 4723篇 |
2013年 | 5128篇 |
2012年 | 7093篇 |
2011年 | 7691篇 |
2010年 | 5857篇 |
2009年 | 4871篇 |
2008年 | 5401篇 |
2007年 | 5056篇 |
2006年 | 4630篇 |
2005年 | 4022篇 |
2004年 | 2746篇 |
2003年 | 2378篇 |
2002年 | 1901篇 |
2001年 | 1373篇 |
2000年 | 1202篇 |
1999年 | 977篇 |
1998年 | 503篇 |
1997年 | 530篇 |
1996年 | 434篇 |
1995年 | 353篇 |
1994年 | 323篇 |
1993年 | 181篇 |
1992年 | 200篇 |
1991年 | 128篇 |
1990年 | 143篇 |
1989年 | 103篇 |
1988年 | 86篇 |
1987年 | 89篇 |
1986年 | 53篇 |
1985年 | 37篇 |
1984年 | 31篇 |
1983年 | 29篇 |
1982年 | 13篇 |
1981年 | 17篇 |
1980年 | 7篇 |
1979年 | 11篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1974年 | 7篇 |
1971年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献
42.
糖尿病腹膜透析患者胰岛素治疗方案探讨 总被引:7,自引:0,他引:7
目的探讨糖尿病腹膜透析(CAPD)患者合理的胰岛素应用方法.方法采用横断面研究方法调查所有接受CAPD治疗至少6个月以上的糖尿病肾病患者的胰岛素使用方案及血糖控制情况.并在横断面研究的基础上,动态观察24例新收的糖尿病CAPD患者透析前、后胰岛素的使用方法、剂量调整方案及血糖控制情况.结果2002年6月至2002年12月间共25例2型糖尿病CAPD患者,其中腹腔内注射胰岛素(IP)6人,皮下注射胰岛素(SC)9人,腹腔和皮下联合应用(IP SC)7人.①空腹血糖、糖化血红蛋白、透析液糖总负荷量、透析液平均糖浓度、透析剂量在IP、SC、IP SC三组间差异均无显著性,(P>0.05);②与IP及IP SC组相比,SC组胰岛素用量明显减少,(P<0.05);③腹膜炎的总发生率为1次/每15患者月,明显高于同期非糖尿病腹膜透析患者的腹膜炎发生率(1次/每48患者月),(P<0.01);④动态观察24例新收的糖尿病CAPD患者,胰岛素剂量较透析前平均增加了(0.33±0.23)倍.透析后调整的胰岛素实际增加量与理论预测增加量差异无显著性,(P>0.05).患者血糖控制良好,平均为(5.81±1.22)mmol/L.结论皮下注射胰岛素是有效控制糖尿病CAPD患者血糖水平的适当途径.腹膜透析后,可在原有皮下应用胰岛素方案的基础上,参照糖吸收量计算需增加的胰岛素用量适当增减胰岛素,能有效控制血糖. 相似文献
43.
目的:研究成釉细胞瘤(AB)和牙源性角化囊肿(OKC)中c-mycmRNA的表达,探讨c-myc在AB和OKC中的发生、发展及其生物学意义。方法:使用原位杂交法检测54例AB、16例OKC和7例口腔正常黏膜(NOM)组织中c-mycmRNA的表达,并将AB按原发、复发、恶变分组,结果使用χ2检验进行统计分析。结果:AB、OKC及NOM组织中c-mycmRNA的阳性表达率分别为81.5%(44/54)、75.0%(12/16)和14.3%(1/7),3组比较有显著性差异(χ2=15.488,P<0.05)。原发组AB中c-mycmRNA的阳性表达率为71.0%,复发组为94.7%,恶变组为100.0%,伴随原发、复发、恶变,差异有显著性(χ2=16.912,P﹤0.05)。结论:c-myc表达在AB的发生、发展中有重要作用;c-mycmRNA的表达与AB的临床生物学行为有关,伴随其生物学行为变化,c-mycmRNA表达增强;提示c-myc有可能成为评价预后的有效指标。 相似文献
44.
45.
Karen M Majchrzak Lara B Pupim Kong Chen Cathi J Martin Sheila Gaffney Jane H Greene T Alp Ikizler 《Journal of renal nutrition》2005,15(2):217-224
OBJECTIVE: To determine physical activity patterns in chronic hemodialysis patients with a specific emphasis on the difference between dialysis and nondialysis days. Design A cross-sectional single-center study. SETTING: Vanderbilt University Outpatient Dialysis Unit. PATIENTS: Twenty current chronic hemodialysis patients: 10 male, 10 female; 15 black, 5 white; mean age, 50.1 +/- 9.9 years; height, 164.5 +/- 10.9 cm; weight, 82.5 +/- 15.4 kg; length on dialysis, 57.3 +/- 45.3 months. METHODS: Minute-by-minute physical activity was assessed over a 7-day period using a triaxial accelerometer, which consists of raw numbers or counts calculated by the 3 axes of the accelerometer (PA counts). PA counts were extrapolated on a daily and hourly basis. Physical functioning tests included: sit-to-stand, 6-minute walk, and 1-repetition maximal leg press exercise. Laboratory values for serum concentrations of albumin, prealbumin, C-reactive protein, and cholesterol were also collected. MAIN OUTCOME MEASURE: PA counts. RESULTS: Total PA counts were significantly lower on dialysis days when compared with nondialysis days (128,279 +/- 74,009 versus 168,744 +/- 95,168, respectively, P = .025). The average PA counts during the 4-hour dialysis time period were significantly lower on dialysis days when compared with nondialysis days (3,086 +/- 3,749 versus 11,070 +/- 7,695, respectively, P = .001). At postdialysis hours 1 and 2, PA counts on dialysis days were significantly higher than on nondialysis days (11,410 +/- 5,340 versus 9,082 +/- 6,646, P = .008, and 14,048 +/- 9,728 versus 8,662 +/- 6,433, P = .016, respectively). By postdialysis hour 4, PA counts on dialysis days had significantly decreased when compared with nondialysis days (6,068 +/- 6,268 versus 10,512 +/- 7,420 PA counts, P = .01, respectively). From postdialysis hours 5 to 20, there was no significant difference in PA counts between dialysis and nondialysis days. CONCLUSION: This study shows that physical activity is lower on dialysis days when compared with nondialysis days, and this decrease is caused by the lack of activity during the 4-hour hemodialysis procedure. New behavior modification strategies involving physical activity, both during hemodialysis and on nondialysis days, must be examined in this patient population. 相似文献
46.
目的:评价泰勒宁片和科洛曲片对隆乳手术后疼痛的疗效和不良反应。方法:采用随机开放平行对照试验。共完成60例,其中A组30例予泰勒宁片,单次1片;B组30例予科洛曲片,单次1片。结果:泰勒宁片对隆乳手术后引起的中度或重度疼痛总有效率可达96.7%,科洛曲片的总有效率可达83.3%。服药后泰勒宁片组的疼痛强度差均高于科洛曲组,经统计学处理,有显著性差异(P<0.05)。不良反应发生率较科洛曲片组高。结论:泰勒宁片为中强度镇痛药,对于隆乳手术后引起的中重度疼痛有良好的镇痛效果。 相似文献
47.
管状膨体聚四氟乙烯用于组织工程支架材料的动物实验研究 总被引:6,自引:0,他引:6
目的:研究膨体聚四氟乙烯(ePTFE)植入动物体内后与机体的关系。方法:管状膨体聚四氟乙烯两端闭合,内充DMEM培养液,埋入家兔皮下,观察宿主生命情况,于术后1、2、4、6周取出标本,行大体及光镜下观察。结果:家兔在植入膨体聚四氟乙烯材料及DMEM培养液后存活情况良好,DMEM培养液在1周时即已完全无色透明;4周时膨体聚四氟乙烯与周围组织有粘连,6周时粘连紧密;光镜下观察,各时间点材料间隙均可见着色,1周时可见少量淋巴细胞浸润,无血管及组织细胞。材料内壁未见细胞附着。结论:植入膨体聚四氟乙烯材料及少量DMEM培养液对宿主动物存活无影响;管内外液体可相互交通,管状膨体聚四氟乙烯可作为组织工程化尿道的支架材料。 相似文献
48.
目的 探讨微创经皮肾镜取石术治疗上尿路结石的有效性和安全性.方法上尿路结石患者368例,平均年龄57岁.其中输尿管上段结石116例,结石大小(2.1±0.8)cm;肾结石252例,结石大小(4.6±1.4)cm,其中非鹿角形结石190例,结石大小(3.2±1.1)cm,鹿角形结石62例,结石大小(7.6±1.6)cm.均采用微创经皮肾穿刺,输尿管镜下气压弹道或联合钬激光碎石治疗,对结石清除率和并发症等进行统计分析.结果 368例患者中单通道取石356例(96.7%),双通道12例(3.3%).一期取石344例(93.5%),二期取石24例(6.5%).总结石取净率为88.6%(326/368).平均手术时间73 min.一期取净结石者住院时间4~8 d,平均6 d.术后发热14例(3.8%);输血5例(1.4%);2例肾结石术后出血严重者经输血及超选择性肾动脉栓塞后治愈.结论 微创经皮肾镜取石术损伤小、住院时间短、术中出血及并发症少、结石清除率高、可重复取石,是治疗上尿路结石有效的微创手段. 相似文献
49.
OBJECTIVE: To study the value of neuronavigation in the transpetroal approach, and to provide anatomic data for the protection of the nerves in the facial nerve canal (FNC) during surgeries. METHODS: Simulated surgery through the transpetroal approach was performed on 16 sides of 8 adult cadaver heads with the assistance by neuronavigation. The anatomy of the facial nerve and the relationship of related structures were observed and the distances from the utmost external edge of the mastoid to different segments of the FNC were measured. RESULTS: Neuronavigation was successful with all the FNC, with the mean error of less than 0.9 mm. The FNC could be divided into 3 segments, the labyrinthine, the tympanic and the mastoid segments, stretching 3.6+/-1.2 mm, 11.2+/-2.5 mm and 16.1+/-3.6 mm respectively and with diameters of 1.2+/-0.3 mm, 1.4+/-0.1 mm and 1.7+/-0.2 mm, respectively. CONCLUSION: Neuronavigation may help protect the FNC during surgical procedures, and a thorough knowledge of the anatomic features of the FNC can be significant for preservation of the facial nerves. 相似文献
50.
Min Zhang Wen-Bin Li Jin-Xia Geng Qing-Jun Li Xiao-Cai Sun Xiao-Hui Xian Jie Qi Shu-Qin Li 《Journal of cerebral blood flow and metabolism》2007,27(7):1352-1368
Glial glutamate transporter-1 (GLT-1) plays an essential role in removing glutamate from the extracellular space and maintaining the glutamate below neurotoxic level in the brain. To explore whether GLT-1 plays a role in the acquisition of brain ischemic tolerance (BIT) induced by cerebral ischemic preconditioning (CIP), the present study was undertaken to observe in vivo changes in the expression of GLT-1 and glial fibrillary acidic protein (GFAP) in the CA1 hippocampus during the induction of BIT, and the effect of dihydrokainate (DHK), an inhibitor of GLT-1, on the acquisition of BIT in rats. Immunohistochemistry for GFAP showed that the processes of astrocytes were prolonged after a CIP 2 days before the lethal ischemic insult, which could protect pyramidal neurons in the CA1 hippocampus against delayed neuronal death induced normally by lethal ischemic insult. The prolonged processes extended into the area between the pyramidal neurons and tightly surrounded them. These changes made the pyramidal layer look like a 'shape grid'. Simultaneously, the prolonged and extended processes showed a great deal of GLT-1. Western blotting analysis showed significant upregulation of GLT-1 expression after the CIP, especially when it was administered 2 days before the subsequent lethal ischemic insult. Neuropathological evaluation by thionin staining showed that DHK dose-dependently blocked the protective role of CIP against delayed neuronal death induced normally by lethal brain ischemia. It might be concluded that the surrounding of pyramidal neurons by astrocytes and upregulation of GLT-1 induced by CIP played an important role in the acquisition of the BIT induced by CIP. 相似文献